3-(4-Oxo-3-phenylthiazolidin-2-yl)-N-(4-phenylbutyl)benzamide

ID: ALA5204316

PubChem CID: 168294130

Max Phase: Preclinical

Molecular Formula: C26H26N2O2S

Molecular Weight: 430.57

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(NCCCCc1ccccc1)c1cccc(C2SCC(=O)N2c2ccccc2)c1

Standard InChI:  InChI=1S/C26H26N2O2S/c29-24-19-31-26(28(24)23-15-5-2-6-16-23)22-14-9-13-21(18-22)25(30)27-17-8-7-12-20-10-3-1-4-11-20/h1-6,9-11,13-16,18,26H,7-8,12,17,19H2,(H,27,30)

Standard InChI Key:  ARAYHOGVDWLVSK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -1.4203   -2.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5944   -1.4662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9805   -0.9109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1700   -1.0818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1681   -1.8381    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2430   -0.3637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3122    0.2509    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0685   -0.0871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7871    0.3234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7871    1.1574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5083    1.5682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5083    2.3966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2294    2.8087    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7946    2.8130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0759    2.4009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3597    2.8172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3588    2.4052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0751    2.8215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7937    2.4095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5059    2.8289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2294    2.4207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2294    1.5880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5123    1.1716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7937    1.5836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2231    1.1538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2231    0.3229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5065   -0.0915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3834   -1.2098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9978   -1.7643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8245   -2.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0314   -2.8289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  9  8  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 24 23  1  0
 19 24  2  0
 11 25  1  0
 25 26  2  0
 26 27  1  0
 27  9  2  0
  2 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31  1  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5204316

    ---

Associated Targets(Human)

HOS-TE85 (154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SJSA-1 (970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOS (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MG-63 (795 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
143B (353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 430.57Molecular Weight (Monoisotopic): 430.1715AlogP: 5.22#Rotatable Bonds: 8
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.16CX LogD: 5.16
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.50Np Likeness Score: -0.95

References

1. Deng Y, Pi R, Niu L, Zhao Y, Ni D, Song L, Li Z, Han W, Wei Q, Han Y, Zhu T, Luo Z, Sun D, Dong S, Liu S..  (2022)  Novel 2-phenyl-3-(Pyridin-2-yl) thiazolidin-4-one derivatives as potent inhibitors for proliferation of osteosarcoma cells in vitro and in vivo.,  228  [PMID:34861640] [10.1016/j.ejmech.2021.114010]

Source